Genomictree Inc.
228760
शेयरों में रैंक
#19154
Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to... Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening solution for the early identification of colorectal cancer. For lung cancer, it offers EarlyTect L, which targets epigenetic markers in patients with pulmonary nodules, and for bladder cancer, EarlyTect B, designed to detect specific genetic and epigenetic markers in individuals with hematuria. The company also provides a range of companion diagnostics: AccuraTect-KRAS and AccuraTect-BRAF assist in colorectal cancer management, while AccuraTect-EGFR supports lung cancer treatment. In addition, Genomictree supplies AccuraDTect SARS-CoV-2 RT-qPCR kits for infectious disease testing, and offers its technologies to support various diagnostic test providers. Founded in 2000, the company is based in Daejeon, South Korea.
शेयर मूल्य
$6.62
मार्केट कैप
$162.43M
बदलाव (1 दिन)
0.10%
बदलाव (1 वर्ष)
-50.88%
देश
KR
व्यापार Genomictree Inc. (228760)
श्रेणी
Healthcare
का बाजार पूंजीकरण Genomictree Inc.(228760)
मार्केट कैप: $162.43M
October 2026 में Genomictree Inc. का मार्केट कैप $162.43M है। हमारे डेटा के अनुसार, यह Genomictree Inc. को दुनिया की 19154th सबसे मूल्यवान कंपनी बनाता है। मार्केट कैप किसी सार्वजनिक कंपनी के सभी जारी शेयरों का कुल बाजार मूल्य होता है और इसका उपयोग आमतौर पर कंपनी के मूल्य को मापने के लिए किया जाता है।
Genomictree Inc. का बाजार पूंजीकरण इतिहास 2017 से 2026 तक
228760 शीर्ष 5 के साथ तुलना में सबसे लोकप्रिय stocks
